Information related to the Combined Shareholders’ Meeting of 27 May 2021

In the context of the Covid-19 epidemic and in accordance with emergency measures decided by the French government, Ipsen’s Board of Directors decided that the Company’s Combined Shareholders’ Meeting, convened for Thursday 27 May 2020 at 3 pm (Paris time), will exceptionally be held behind closed doors, without the physical presence of shareholders and other persons entitled to attend, at the Company’s headquarters, 65, Quai Georges Gorse, 92100 Boulogne-Billancourt (France).

This Meeting will be broadcast live and in full in video format, in French and English on the Company’s website.

 

It is specified that shareholders will not be able to participate and vote on live due to the technical impossibility to proceed to their identification.

 

No admission cards will be issued for this Shareholders’ Meeting. Shareholders will have to vote remotely before the Meeting is held (by post or online on the secure Votaccess voting platform) or give a proxy to the Chairman of the Meeting. They still have the possibility to give a proxy to a third party, who will have to send voting instructions by electronic mail to the address mentioned in the notice of Meeting. It is highly recommended to vote online or send the voting form as soon as possible.

 

Shareholders are invited to regularly consult the Investors / Shareholders’ Meeting section on the Company’s website: www.ipsen.com.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021